Anthropic Trust appointed Novartis CEO Vas Narasimhan to its board of directors, giving Trust-appointed directors a majority for the first time. Narasimhan’s appointment by the Long-Term Benefit Trust aligns with Anthropic’s public benefit mission. This move comes as Anthropic considers an IPO and expands its healthcare focus through Claude initiatives.

Leave a Reply